October 18, 2025 - 04:48

Private equity firms TPG and Blackstone are reportedly close to finalizing a significant acquisition of the medical technology company Hologic. This deal, if completed, would mark one of the largest take-private transactions of the year, showcasing the growing interest from private equity in the healthcare sector.
Hologic, known for its innovative products in women's health, diagnostics, and medical imaging, has been a key player in the industry. The potential acquisition reflects the increasing appetite among investment firms to capitalize on the expanding healthcare market, particularly in the wake of heightened demand for medical technologies.
The negotiations between TPG and Blackstone indicate a strategic move to leverage Hologic's strong position in the medical technology landscape. As the deal progresses, it is expected to attract significant attention from investors and analysts alike, highlighting the ongoing trend of consolidation within the healthcare industry. This acquisition could reshape the future of medical technology and provide new opportunities for growth and innovation.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...